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- Fromthe ••1-11 President --
These are the lazy, hazy, crazy days of 
summer, so I promise to keep this 
brief. 
Things have been relatively quiet on 
the Medical Staff front these last few 
weeks. While the Medical Executive 
Committee has several works in 
progress, only one topic reached its 
conclusion at our last meeting --
"Consultation Guidelines." As a 
tertiary care center, we, as a staff, 
generate a significant number of 
consultations each day. Many 
physicians have noticed, however, that 
a sense of collegiality and decorum is 
often missing. A consult which is 
called to an office or an answering 
service and reads "patient known to 
you" can often leave a potential 
consultant guessing about the urgency 
of the consultation and the role she/he, 
as a consultant, is being asked to play. 
As a result of discussions generated by 
the Medical Executive Committee's 
own David Caccese and John 
V anBrakle, the attached "Consultation 
Guidelines" document was generated. 
The basic theme is that we should 
reintroduce the personal touch, if it is 
lacking, between primary caregiver 
and consultant. I'd ask that you keep 
an open mind and read it through. If it 
makes sense, let's try to instill these 
principles as part of our Medical Staff 
culture. 
Enjoy the rest of the summer! 
~· 
Robert X. Murphy, Jr., MD 
President, Medical Staff 
Medical Staff Trivia 
Of the 820 members of the 




The New Technology Committee 
approved the use ofProstascint studies 
at Lehigh Valley Hospital as of June 
10. Studies have begun on patients 
who fall within the guidelines for the 
use ofProstascint. Currently, L VH is 
the only facility in the area able to 
perform Prostascint studies; and we 
will actually serve to certify other 
physicians to do these procedures. As 
there is a very large backlog of 
patients who need to have these 
studies performed, your patience is 
appreciated as we try to get to all of 
them. 
If you have questions regarding 
Prostascint studies, please contact Paul 
S. Sirotta, MD, in Nuclear Medicine at 
402-8383. 
17th & Chew Renovations 
The final renovation plans for the 
Radiology Department at 17th & 
Chew have been approved. This plan 
will relocate Ultrasound from the first 
floor to the ground floor and will 
consolidate the entire Radiology 
Department on one floor. 
Construction is scheduled to begin in 
September or October and will take 
approximately three to four months to 
complete. 
Report Turnaround Time 
In an effort to improve report 
turnaround time, the Radiology 
Department requests your assistance. 
When you sign out films from 
Radiology, please try to return them 
within 48 hours. Through the use of 
electronic tracking with the new 
radiology system, the process of 
releasing films to physicians will 
improve dramatically. 
New Radiology System 
The Radiology Department is on track 
to implement the new Radiology 
Information System on August 26. 
With this new system, the process of 
listening to dictation reports will be 
streamlined. You will no longer need 
to look up the accession number in the 
Phamis system to listen to the dictated 
report on the Lanier dictation system. 
You will simply enter the patient's 
medical record number to access the 
patient's report. 
Last year, a survey regarding incorporation of 
technology into medical education was 
distributed as part of the hospital's Strategi 
Plan for Medical Education. As a follow-up, a 
residency education survey is included with 
this issue of Medical Stag Progress Notes 
which focuses on the use of technology in 
resident learning. This survey is intended to 
give post-graduate faculty an opportunity to 
voice their opinions on the use of technology 
here at Lehigh Valley Hospital. 
As new technologies such as Virtual Reality 
and Interactive Multimedia continue to 
develop, we need to assess our educational 
techniques and learning tools. Your answers 
and comments will help the Center for 
Educational Development and Support to fine 
tune our services in order to provide you with 
the best support possible. 
Please complete and return the survey by 
August 22 to Dean Shaffer, Center for 
Educational Development and Support, John 






Policy Change •.. Administrative Policy AD 1601.00 -
· Restraint an·d Seclusion 
In July of 1996, the Joint Commission 
on Accreditation for Healthcare 
Organizations released a set of 
standards that addressed the use of 
restraint and seclusion in JCAHO 
accredited organizations. The 
JCAHO's goal for the revision is to 
assure that the patient's need for the 
restraint is assessed and that 
alternatives are attempted before 
restraints are utilized. The 
standards are very specific and are 
responsible for more Type 1 
recommendations than any other 
standard. The following changes 
have been made in order to assure our 
compliance with the above mentioned 
standards and will be implemented on 
August 1, 1997: 
The Administrative Policy (attached) 
has been revised to reflect the new 
standards. The modifications include 
the following: 
• Restraints may be used without a 
physician's order when they are 
considered part of"standard care" 
or when the protocol is initiated. 
Standard care is defined as: use of 
restraints during transport via 
wheelchair, stretcher, etc.; during 
medical, diagnostic, surgical 
procedures or tests; as adaptive 
support; or as protective devices. 
The Protocol Guiding the Use of 
Immobilization Devices for the 
Sedated/ Anesthetized, Brain 
Injured/Cognitively Impaired 
Patient allows for restraints (soft) 
to be utilized when the less 
restrictive interventions are 
ineffective and the patient is in 
imminent danger to self or others. 
• Customary patient care and regular 
hourly observation is performed 
and documented in the patient's 
medical record. 
• When restraints are used for 
reasons other than those noted 
above, the following must occur: 
if restraints are applied 
emergently, the physician is to be 
notified immediately and a verbal 
order received within one hour 
(verbal orders must be dated and 
timed when written and co-signed 
by the physician within 24 hours); 
a Doctors Order Sheet has been 
developed in order to assure that 
all components of the order are 
present; the order for restraint is 
time-limited and cannot exceed 24 
hours; in order to continue the 
use of restraint beyond the 24 
hour time limit, a face-to-face 
assessment must be completed 
by the physician and a new 
order written; the patient is to be 
observed every 15 minutes and the 
results of the observation is 
documented on the Restraint and 
Seclusion Flowsheet; customary 
patient care will be provided as per 
the policy. 
• Additional requirements for 
patients with primary behavioral 
health needs (patients admitted to 
the Psychiatric Unit or the · 
Emergency Department) include 
the physician order be time-limited 
for no more than 4 hours for 
adults, 2 hours for children and 
adolescents (ages 9-17) and 1 hour 
Continued on Page 4 
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(Continued from Page 3) 
for children under age 9; the 
physician order·may specify that 
the RN may continue the original 
order for up to 24 hours after a 
reassessment is completed by the 
RN and documented in the 
patient's medical record. 
• PRN orders are not acceptable 
In addition to the policy, attached you 
will find a copy of the Doctor's Order 
Sheet, the Restraint/Observation 
Checklist, and a copy of the Restraint 
Alternatives Decision Tree that has 
been incorporated into the Patient 
Care Services Patient Seclusion/ 
Restraint Policy. 
Additional information for completion 
of the Doctor's Order Sheet: 
• the order must be dated and timed 
to be initiated (only way to track 
the length of time the order is in 
effect) 
• the restraint device must be 
indicated with a check 
• the purpose for the 
restraint/seclusion must be 
checked (may indicated more than 
one reason) 
• the criteria for discontinuing 
restraint/seclusion must be 
checked 
• a definitive period of time must be 
specified (cannot exceed 24 hours) 
• psychiatry/behavioral health 
patients only (patients admitted to 
the psychiatric unit or emergency 
department) must have the 
appropriate time frame checked (if 
the RN is to continue the original 
order for additional periods of time 
that must be noted) 
• the order sheet must be signed 
For additional information or for 
clarification, please contact Beverly 
Snyder in Risk Management at 402-
5218, or Karen Peterson, Patient Care 
Specialist, Department of Psychiatry, 
at 402-2813. 
As we continue to prepare for our 
JCAHO survey •.. 
Standard TX.4 requires that "each 
patient's nutrition care is planned." 
All patients, regardless of their 
nutritional status or need, receive a 
prescription or order for food or other 
nutrients. The food or other nutrient 
ordered can range from nothing by 
mouth (NPO orders), to regular diets, to 
parenteral or enteral tube nutrition. 
Standard TX.4.2 states that 
"authorized Individuals prescribe or 
order food and nutrition products in , 
timely manner." 
Food and nutrition products are 
administered only when prescribed or 
ordered by medical staff, authorized 
housestaff, or other individuals with 
appropriate clinical privileges. Verbal 
prescriptions/orders are authenticated 
within the timeframe specified in the 
medical staff bylaws and such orders for 
food are documented in the patient's 
medical record before any food or other 
nutrient is administered to the patient. 
Remember to: WRITE A DIET ORDER 
FOR EVERY PATIENT 
The above standards will be 
surveyed during the visits to patient 
care areas (open medical record review) 
and also during the closed medical 
record review. The surveyors will look 
for a diet order on every patient's 






New Surgical Procedure Benefits Patients, Hospital 
Two L VH colon and rectal surgeons --
Robert D. Riether, MD, and John J. 
Stasik, MD -- have introduced a new 
surgical procedure to the Lehigh 
Valley that will benefit the patient and 
the health care system with fewer 
complications, shorter hospital stays 
and lower costs. 
Transanal Endoscopic Microsurgery 
{TEM) is emerging internationally as a 
minimally invasive means of resecting 
certain rectal tumors. Drs. Riether and 
Stasik introduced the procedure in 
May at L VH after completing an 
intensive training course in Tubingen, 
Germany. As such, LVHjoins less 
than 10 institutions in the United 
States that have successfully 
performed TEM. 
Developed in Germany, TEM uses 
either a 12 em or 20 em operating 
rectoscope and specialized 
instrumentation to remove adenomas 
that are small, large, or even 
circumferential, as well as selected 
carcinomas up to 24 em. Most 
significantly, TEM is an alternative to 
an open transsacral or transabdominal 
approach for lesions in the mid and 
upper rectum. 
Traditionally, patients diagnosed with 
early malignant rectal tumors or 
benign distal colonic polyps greater 
than 2 em have been treated with a 
transanal or transabdominal resection; 
the minimal stay for such major 
abdominal surgery is usually seven to 
1 0 days. If the lesion was in the distal 
third of the rectum and not more than 
9 em, colon-rectal surgeons have 
attempted a transanal resection (e.g. 
Kraske's, York-Mason's, or Bacon 
pull-through procedure). Although 
less invasive than the abdominal 
approach, a transanal excision may 
require a prolonged intraoperative 
resection and as many as three to four 
inpatient days. 
Experience with TEM at L VH and in 
Germany, Italy and Japan-- where it 
already is being used as a standard 
treatment -- shows the following 
benefits for patients who are 
candidates for this procedure: 
• No abdominal incision or 
colostomy. 
• Dramatically less pain and 
minimal risk ofpost-op infection. 
• Discharge from hospital within 
one to two days. 
• Return to normal activity 
expeditiously. 
• Reduced intraoperative surgical 
and anesthesia time. 
• Lower hospital costs and improved 
outcomes. 
A team consisting of a primary 
physician, gastroenterologist and/or 
colon-rectal surgeon will evaluate 
potential patients and provide follow-
up care. If you feel you have a patient 
who could benefit from TEM or would 
like more information about the 
procedure, please call the Lehigh 
Valley Hospital Physician-to-
Physician Hotline at 1-800-LVH-
2040. We look forward to 
collaborating with you in the care of 
your patients. 
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Use ofNew Patient Transfer Form Begins August 1 
Important changes have been made to 
the Patient Transfer Form. Input from 
physicians, patient care services staff, 
clinical resource management staff, 
ancillary departments and receiving 
facilities personnel served as a 
foundation for these changes. This 
form replaces both the medlsurg and 
critical care transfer forms ( #NSG-61-
1 and NSG-61-2). 
The revisions are as follows: 
1. There is now a place where the 
physician can check to indicate 
authorization for transfer to an SNF or 
other acute care facility. 
• Previously, the physician's signature 
authorized only a transfer to an SNF 
even though the form was also used 
to transfer to acute care facilities. 
2. The Surgical Procedure Section 
will now be completed by the Clinical 
Resource Manager. 
• Information is easily retrieved from 
the Operative Report. 
• Physician time needed to fill out form 
will be decreased. 
3. Physicians will need to complete 
all sections in the PHYSICIAN 
SECTION. (Only the attending or his 
physician designee may sign the 
orders.) 
• This section represents the doctor's 
orders that are to be followed for the 
patient until the receiving facility's 
physician writes new orders. In the 
case of an SNF, physician orders are 
a requirement of the written contract 
between the hospital and'the SNF. 
• The doctor CANNOT give a verba) 
order to a nurse because all verbal 
orders have to be signed within 24 
hours -- which would be impossible 
in most cases. 
Exceptions: 
• The nurse caring for the patient will 
note when the last dose was given on 
any medication that the patient was 
on in the hospital. This is to be done 
for all the medications listed by the 
physician in the Medication Section. 
• The nurse will fill in PTIINR and 
Coumadin dose given on the day of 
discharge. This information was 
requested by the SNF's. 
4. Page 2, completed by the patient's 
nurse and other caregivers, has been 
expanded so that the receiving facilitv 
will have comprehensive, easily ) 
retrievable information needed to care 
for the patient on arrival. 
• Receiving facilities were often unsure 
of where to locate information about 
the patient on the chart copy 
accompanying the patient. 
5. The Patient Care Services staffwill 
no longer be permitted to release a 
patient from the unit unless the Patient 
Transfer Form is completed and 
signed by the physician. 
• The SNF's have said that they Will 
not accept a patient unless the patient 
is accompanied by a completed 
Patient Transfer Form, signed by a 
physician. 
If you have any questions regarding 
this form, please contact Carol 
Balcavage, Coordinator, Enterostor. ) 




Pocono Medical Center Joins Penn CARE 
-· 
Pocono Medical Center, East 
Stroudsburg, and members of the 
affiliated physicians' organization, 
have joined the Penn CARE integrated 
health care delivery system, a network 
of hospitals, physicians and other _ 
providers offering a full range of 
prevention and treatment services to 
communities throughout eastern 
Pennsylvania. 
The addition of Pocono Medical 
Center and the physicians' 
organization to PennCARE brings the 
number of hospitals to 10, with 
combined medical staffs of 2,327 
physicians. More than 1.87 million 
residents live in the counties now 
served by PennCARE providers, an 
area measuring 5,475 square miles. 
Pocono Medical Center is a 192-bed 
acute care hospital with an active and 
provisional medical staff that numbers 
120 -- 25 primary care physicians and 
95 specialists, all board certified or 
board eligible. The system serves 
residents in Monroe, southern Pike, 
and northern Northampton counties. 
The hospital provides specialized care 
in cardiology, obstetrics, general 
surgery, pulmonary medicine, 
gastroenterology, behavior health, and 
orthopedics, and features a new 23-
bed skilled nursing facility. 
"Pocono Medical Center and its 
medical staff share a commitment to 
their community that is common to all 
in the PennCARE network," said 
Elliot J. Sussman, MD, chairman of 
the board and president of PennCARE. 
''The decision by the hospital and the 
physician organization to become 
partners with nine other local health 
systems measurably strengthens the 
network. More importantly, it 
expands the scope of services 
available to local residents and 
increases local health care providers' 
options for participation in integrated 
systems." 
PCC Update: Phone Cal{s to RNs 
Is the phone line busy when you try to 
reach the RN cell phone? Do you get 
upset because of the frequency of this 
occurrence? 
A recent two-day study of incoming calls 
to RNs on 7 A revealed an alarming trend 
-- one-quarter to one-half of the calls in 
an eight-hour period were unnecessary to 
be made to the RN and could have been 
handled by someone else. The average 
number of calls to the RN was 35 calls 
during the shift. 
To address this growing dilemma, a team 
comprised of clinical, administrative, and 
support members met, discussed, and 
developed a "Telecommunications 
Communication Plan." It is designed to 
direct only critical calls to the RN, and 
involve the technical, support, and 
administrative partner in calls that are 
more appropriate to their roles. The plan 
will be introduced on the PCC units in 
August. 
The plan is intended to free up RN 
phones so they only field calls from 
physicians, patient families, and emergent 
patient care issues. It is anticipated that 
you will find the phone lines to the RNs 
less busy thereby improving the care of 
the patient and our customer service. 
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News from the Library 
OVID Training 
To schedule a one-on-one OVID 
(MEDLINE) training session, call 
Barbara lobst in the Health Sciences 
Library at 402-8408. 
New Books 
The 1997 edition of the Report of the 
Committee on Infectious Diseases, 
also known as the "Red Book," is now 
available in the Reference Section of 
the Cedar Crest & 1-78 and 17th & 
Chew libraries. 
Light Reading 
If you would like a break from 
"heavy" reading, the following titles, 
authored by Stephen Covey, may be 
borrowed from the Cedar Crest & 1-78 
Health Sciences Library: 
Congratulations! 
Michael J. Marcinczyk, MD, one of 
this year's graduating Chief Surgical 
Residents, won the Bosanac Research 
and Publication Award for his paper, 
"Asymptomatic Carotid 
Endarterectomy: Patient and Surgeon 
Selection," which was published in the 
journal, Stroke. His paper also 
received the Stahler-Rex Surgical 
Research Paper Award. Co-authors of 
the paper include Gary G. Nicholas, 
MD, Chief, Division ofVascular 
Surgery, and Program Director of the 
General Surgery Residency; James F. 
Reed lll, PhD, Director of Research; 
and Susan A. Nastasee, Surgical 
Editor, Department of Surgery. 
• Daily Reflections for Highly 
Effective People 
• First Things First: To Live, to 
Love, to Learn, to Leave a 
Legacy (book and audio book) 
• The Seven Habits of Highly 
Effective People: Restoring the 
Character Ethic 
• The Seven Habits of Highly 
Effective Families (audio book) 
Charles C. Worrilow, MD, 
Department of Emergency Medicine, 
recently received notification that he 
successfully completed the 
certification examination and has 
become certified as a Diplomate of the 
American Board of Emergency 
Medicine. 
In an effort to assess computer system 
strengths, weaknesses, and opportunities 
for improvement, please take a few 
moments to complete the attached 
Information Management Survey and return 
to Nancy O'Connor, Information Services, 
2024 Lehigh Street, Allentown, PA 18103, 








Papers, Publications and Presentations 
The paper, "Arterial Embolization is a 
Rapid and Effective Technique for 
Controlling Pelvic Fracture 
Hemorrhage," has been accepted for 
publication in the September 1997 issue 
of the Journal of Trauma. The study's 
authors include Stafano F. Agolini, 
MD, Chief Surgical Resident; 
Kamalesh T. Shah, MD, Division of 
General Surgeryffrauma-Surgical 
Critical Care; James W. Jaffe, MD, 
and James A. Newcomb, MD, Division 
of Diagnostic Radiology; Michael 
Rhodes, MD, Chief of Surgery at the 
Medical Center of Delaware; and 
James F. Reed III, PhD, Director of 
Research. ' 
George A. Arangio, MD, Division of 
Orthopedic Surgery, was the primary 
author of a research paper published in 
Clinical Biomechanics. The title of the 
study was "Biomechanical Study of 
Stress in the Fifth Metatarsal." In 
addition, he was also the primary author 
of a research paper published in 
Clinical Orthopaedics and Related 
Research. The title of the study was 
"Effect of Cutting the Plantar Fascia on 
the Mechanical Properties of the Foot." 
Brian L. Fellechner, DO, Division of 
Physical Medicine/Rehabilitation, 
presented "Treatment of Chronic Pain 
with Sphenopalatine Ganglion Block: 
A Review of a Decade of Clinical 
Experience" at the American 
Osteopathic College of Rehabilitation 
Medicine/Greater Philadelphia Pain 
Society combined annual meeting held 
in Philadelphia. 
Stephen K. Klasko; MD, Chairperson, 
Department of Obstetrics and 
Gynecology, was featured in both OB-
GYN News (May 1, 1997) and the 
Obstetrician & Gynecologist Edition of 
the Medical Tribune (April3, 1997) for 
his innovative new programs included 
in the residency program. These 
include training in time management, 
patient interaction skills, community 
outreach, and the business aspects of 
practice. Dr. Klasko described the 
program at the recent joint annual 
meeting of the Council on Resident 
Education in Obstetrics and 
Gynecology (CREOG) and the 
Association of Professors of 
Gynecology and Obstetrics (APGO) in 
New Orleans, La. In addition, Dr. 
Klasko's article, "Educating Residents 
to Thrive and Prosper in the Twenty-
First Century or Tales from the Dark 
Side: Applying Business Modules for 
the Benefit of Patients and Providers," 
was featured as part of the Annual 
Meeting Highlights in Volume XXV, 
No. 1 of The APGO Reporter. 
Orion A. Rust, MD, Chief, Section of 
Clinical Obstetrics, co-authored a 
number of papers which were recently 
published. "The Origin of Endothelin-1 
in Patients With Severe Preeclampsia," 
and "A Randomized Trial of Two 
Vacuum Extraction Techniques," were 
both published in the May, 1997 issue 
of Obstetrics & Gynecology. "Twins 
and Preterm Labor" was published in 
the April, 1997 issue of The Journal of 
Reproductive Medicine. 
Patrice M. Weiss, MD, Division of 
Primary Obstetrics and Gynecology, 
was the keynote speaker at Women's 
Health 1997, a program sponsored by 
Geisinger Wyoming Valley on April 16 
at East Mountain Inn in Wilkes-Barre, 
Pa. Dr. Weiss presented "Health Issues 
Facing Today's Women." In addition, 
Dr. Weiss was a guest speaker at the 
May 1 meeting of Executive Women 
International. Her topic for the meeting 
was "Seasons of a Woman's Life." 
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Upcoming Seminars, Conferences and Meetings 
Psychiatry Grand Rounds 
The Department of Psychiatry is 
pleased to announce that Dr. Paul 
Keck of the University of Cincinnati 
will present "Medical Management of 
Bipolar Disorder" on Thursday, 
August 28, from noon to 1 p.m., in the 
hospital Auditorium at 17th & Chew. 
Who's New 
The Who's New section of Medical 
Staff Progress Notes contains an 
update of new appointments, address 
changes, status changes, etc. Please 
remember to update your directory and 
rolodexes with this information. 
Medical Staff 
Appointments 
Anjam N. Bhatti, MD 
(solo) 
1726 Sequoia Court 
Allentown, PA 18104 
(610) 530-0087 
Department ofMedicine 
Division of General Internal Medicine 
Provisional Active 
Jeaninne M. Einfalt, DO 
Coopersburg Medical Associates 
629 W. State Street 
Coopersburg, P A 18036-1955 
(610) 282-4646 
FAX: (610) 282-2513 
Department ofMedicine 
Division of General Internal Medicine 
Provisional Active 
For your convenience, a light 
luncheon will be served between 
11 :45 a.m. and noon. 
For more information, contact Bruce 
Curry in the Department of Psychiatry 
at 402-2810. 
Douglas G. Field, MD 
Milton S. Hershey Medical Center 
Department of Pediatrics 
500 University Drive 
P.O. Box 850 
Hershey, PA 17033-2391 
(717) 531-5901 
Department of Pediatrics ) 
Division of Gastroenterology 
Provisional Associate 
Debra L. Kruse, MD 
ABC Pediatrics 
Allentown Medical Center 
401 N. 17th Street 
Suite 203 
Allentown, P A 181 04-6805 
(610) 821-8033 
FAX: (610) 821-8931 
Department of Pediatrics 
Division of General Pediatrics 
Provisional Active 







(Continued from Page 10) 
Howard E. Kolin,. MD 
Milton S. Hershey Medical Center 
Department of Pediatrics 
500 University Drive 
P.O. Box 850 
Hershey, PA 17033-2391 
(717) 531-5901 
Department ofPediatrics 
Division· of Endocrinology 
Provisional Associate 
Brent M. Nickischer, DO 
Macungie Medical Group 
3261 Route 100 
Box 487 
Macungie, P A 18062-9389 
( 61 0) 966-4646 
FAX: (610) 965-6201 
Department of Medicine 
Division of General Internal Medicine 
Provisional Active 
Sharon J. Schubach, MD 
Medical Imaging of LV, PC 
Lehigh Valley Hospital 
Cedar Crest & 1-78 
P.O. Box689 
Allentown, PA 18105-1556 
( 61 0) 402-8088 
FAX: (610) 402-1023 
Department of Radiology/Diagnostic 
Medical Imaging 
Division ofDiagnostic Radiology 
Provisional Active 
Leave of Absence 
Larry B. Feldman, MD 
Department of Medicine 
Division of General Internal Medicine 
(From 8/1197 to 7/31/99) 
Paul Guillard, MD 
Department of Medicine 
Division of General Inte~al Medicine 
(From 6/1197 to 5/31199) 
Ajay M. Parikh, MD 
Department of Medicine 
Division of General Internal Medicine 
(From 4114/97 to 4/13/98) 
Status Change 
Lisa H. Medina, MD 
Department of Family Practice 
From Active to Affiliate 
Edward A. Schwartz, DPM 
Department of Surgery 
Division of Orthopedic Surgery 
Section of Foot and Ankle Surgery 
From Provisional Active to 
Provisional Affiliate 
Address Change 
Thomas A. Ward, MD 
1251 S. Cedar Crest Blvd. 
Suite 309C 
Allentown, P A 181 03-6205 
Resignation 
Natalie A. Yurick, MD 
Department of Medicine 
Division of General Internal Medicine 
Practice Name Change 
Candio, Kovacs & Lakata, PC 
Joseph A. Candio, MD 
Robert J. Kovacs, MD 
Thomas J. Lakata, DO 
Larry B. Feldman, MD (LOA) . 
Paul Guillard, MD (LOA) 
Primary Care Associates in the 
Lehigh Valley, PC 
David Stein, DO 
Shawn Ruth, DO 
(Continued on Page 12) 
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(Continued from Page 11) 
New Practice Affiliation and 
Address Change 
Judith N. Barrett, MD has joined the 
practice of 
Primary Care Associates in the Lehigh 
Valley, PC (David Stein, DO) 
Her office will be located at 
1028 N. 19th Street 
Allentown, PA 18104-3762 
(610) 437-1288 
Allied Health Professionals 
Appointments 





Dr. Y. Khan) 




(John J. Cassel, MD, PC) 
Greta Flederbach, PA 
Physician Extender 
Physician Assistant 
(Coordinated Health Systems- Dr. M. 
Busch) 




(Allentown Anesthesia Associates -
Dr. Maffeo) 
""': 
Effective July 21, the members of Lehig1, 1 
Valley Family Health Center (William L. 
Miller, MD, Elizabeth L. Stanton, MD, 
Brian Stella, MD, and Headley S. White, 
Jr., MD) and Southside Family Medicine 
(Neal J. Berkowitz, MD, Louis E. Spikol, 
MD, and Mark Wendling, MD) have 
combined inpatient services at Lehigh 
Valley Hospital known as Family 
Practice Service. The goal of this 
service is to create a more efficient and 
coordinated approach to the delivery of 
primary care and to enhance teaching of 
Family Practice residents and students. 
Both groups will continue to maintain 
separate outpatient offices and practices. 
If you have any questions, please contact 







GUIDELINES FOR CONSULTATIONS 
Physicians are professionals, and as professionals, expect and deserve a certain amount of 
respect from their physician colleagues. We have had some discussions about the process 
of requesting and performing consultations at this hospital, and how this process might be 
improved. 
The following suggestions are offered as "guidelines" both for physicians requesting 
consultations, and for physicians performing consultations. Much of what follows has been 
previously suggested by Dr. John VanBrakle and is not original with me. Also, much of 
what follows is simply a reflection of the type of professional behavior which I believe all 
of us learned at one time, but are now often too busy to follow. In addition, I believe that if 
the "guidelines" were followed we would significantly improve professional and patient 
communication, improve the quality of patient care, and reduce the cost of the care which 
we deliver to our patients. 
Remember, the request for a consultation from the attending physician to another physician 
or health care professional is a request for an opinion regarding a specific issue related to the 
patient's diagnosis or care. 
• The consultation request should address a specific question or a specific need. e.g . 
"Please help diagnose my patient's problem", "Please recommend the best treatment 
for my patient's condition", "Please evaluate my patient medically before a planned 
operation", or "Please see my patient for possible abdominal aortic aneurysm repair", 
etc. 
• A personal call to the consultant from the attending physician stating the reason for 
the consultation request, what is expected from the consultant, and whether orders 
should be written by the consultant is appropriate, encouraged, and a simple 
professional courtesy. The attending/referring physician may know or have 
information about the patient which is not available in the medical record which 
would be helpful for the consultant to know. 
• It should be clear in the consultation request whether the attending physician is 
requesting the consultant's advice, opinion, or direct involvement in the patient's care. 
• "Courtesy Consultations" are appropriate and should be placed to physicians who 
have been closely involved with the patient's care, but whose opinion is not 
necessarily needed or required by the attending physician. An example would be a 
"courtesy consultation" to the patient's family physician by the attending surgeon 
who is preparing the patient for an uncomplicated mastectomy. A patient charge 
should not be generated for a "courtesy consultation". 
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• "Teaching Consultations" are also appropriate for the benefit of residents in training 
and medical students wheri · an interesting or unusual patient problem becomes 
apparent to the attending physician, but the services of another physician are not 
necessarily required. Patients should be informed that their problem is unusual or 
interesting and asked if it would be acceptable to have another physician and some 
resident physicians stop by to review the patient's record and briefly interview and 
examine the patient. A patient charge should not be generated for a "teaching 
consultation". This type of consultation is in the best interest of the goals of a 
teaching institution, its medical staff, resident physicians, and students. 
• It should be made clear at the time of the request for the consultation whether the 
attending physician wants the consultant to discuss his/her findings and 
recommendations with the patient and the patient's family or whether the 
recommendations should be discussed with the attending physician either solely or 
primarily. 
• The consultant should always introduce him/herself to the patient and his family if 
they are present. He/she should inform the patient and family that he has come to see 
the patient at the request of the attending physician and should mention the referring 
physician by name. He/she should specify why he was asked to see the patient by the 
referring physician. It is also helpful to ask the name of the patient's primary care 
physician. . After the evaluation the consultant should tell the patient that he will 
discuss his findings and recommendations with the patient's attending physician and 
that together they will develop a plan for the patient's future care. 
• It is useful for the consultant to provide his professional card or to provide his name 
in writing to the patient and his/her family. 
• After the consultation is performed, a personal call from the consultant to the 
attending physician detailing the findings, recommendations, and suggestions 
regarding the further involvement of the consultant in the patient's care is appropriate 
as a professional courtesy and in the interests of the highest quality patient care. The 
initial question asked by the attending physician should be answered by the consultant 
at this time. 
• At this point, it should be clarified as to whether the attending physician wants to · 
write all of the orders in the patient's chart or whether the consultant has the authority 
to write orders for diagnostic tests and treatments. 
• The consultant should not write an order for another consultant to see the patient 
without discussing this with the attending physician. The consultant should not Qrder 
an invasive diagnostic or therapeutic procedure for a patient without first discussing 












by the attending physician. You are offering an opinion which the attending 
physician may or may not choose to follow. 
As a consultant, discuss the need for post discharge follow up of the patient with the 
attending physician. 
If the consultation request is for "patient management" and the consultant feels that 
the extent ofhislher involvement would be best served by a transfer from the referring 
physician to the consultant's service, this should be discussed with the attending 
physician after the patient is seen and evaluated. 
The consultation report should be completed before the consultant leaves the patient 
care unit. This note should answer the question which was originally addressed in the 
consultation. The note may be brief, but should be followed by a longer more 
detailed note, preferably one which is dictated and transcribed so that it will become 
a legible part of the patient's permanent medical record. References can be provided 
if useful, but not simply to "show off'. 
It is useful to have a copy of the detailed consultation report mailed to the attending 
physician as well as to the patient's primary care physician. 
As a consultant, never criticize the previous or present treatment to the patient or 
his/her family. 
• As a consultant, if you have strong objections to the patient's present diagnosis or 
treatment, do not start an argument in the medical record. Discuss you opinions with 
the referring physician directly. 
• As an immediate response it is acceptable to say "I don't know, but I will find out" 
or "I need a little time to think and/or talk this over with someone else". This is 
preferable to guessing. If you really don't know -look it up! 
Hopefully by following the above simple guidelines we will improve communication 
between physicians and between physicians and patients. This improvement in 
communication will lead to better professional relationships between physicians and health . 
care providers and may significantly reduce the risk of medical malpractice. I believe that 
if these guidelines are followed we also may see a significant reduction in the duplication of 
studies and in the cost of care which we deliver to our patients. 
David M. Caccese, M.D. 





A Service of lEHq;HVAILEY 
HOSPITAL 
Cardiac Troponin I 
Cardiac Troponin I is both a sensitive and specific marker 
for the detection of myocardial injury. As a component in 
our 3-specimen serial Ml profile it challenges CKMB as 
the optimal marker for acute myocardial infarction. Once 
it turns positive (within 3-4 hours of an infarction) it 
remains elevated for several days. Troponin I has been 
so clinically diagnostic as a cardiac marker that CKMB 
(the current gold standard test) is being dropped by many 
laboratories as a routine cardiac marker test, especially in 
today's climate of decreasing hospitalization costs. More 
about this to follow at a later time. 
However. the laboratory has received several reports by 
physicians of decidedly false positive Troponin I values. 
Indeed this was correct. We identified the problem as 
being due to the presence of microclots in the 
heparinized plasma specimens interfering with the 
measurement and resulting in sporadically elevated 
values. At the same time, a paper in Clinical Chemistry 
43, No.5, p. 860 (1997) reported the same observation 
and came to the same conclusion. We hope that the use 
of heparinized plasma specimens centrifuged at room 
temperature for a minimum of 10 minutes followed by 
visual inspection of the sample for microclots will avoid 
false positive Troponin I results. If microclots are still 
visually observed, the specimen will be recentrifuged for 
an additionat10 minutes and reinspected. This protocol 
should solve the problem. 
Finally, as a quality assurance check, Total CK, CKMB 
and Troponin I will all be reported at the same time. The 
CKMB determination requires a serum specimen which 
would often not clot because the patient was receiving 
heparin. We are adding thrombin to these CKMB 
specimens to promote clotting resulting in more rapid 
testing. 
We expect that this new protocol for handling Ml profile 
specimens will eliminate false positive results and 
improve general turnaround-time. If you feet that any ) 
results are still questionable, please notify the laboratory 
ASAP so that we can putt the specimen and investigate 
the problem. 
John J. Shane, MD 
Chairperson, Department of Pathology 
Health Network Laboratories 
Gerald E. Clement, Ph.D. 
DABFT,DABCC,DABCT 
Technical Director, 






July 14, 1997 
Dear Medical Staff Member: 
1243 South Cedar Crest Boulevard 
Allento\\'n. Pennsylvania 18103-6296 
L VH currently spends more than $50 million annually on supplies. This figure includes 
specialty products (e.g., pacemakers, ortho implants), common medical/surgical products (e.g., 
IV tubings, disposable packs and gowns), imaging and laboratory supplies, and pharmaceuticals. 
Market data available from sources such as Mecon and ECRI (a non-profit organization that 
assists hospitals with supply and equipment spending) suggest that organizationally we can 
maintain or improve the quality of care while reducing the amount we spend on supply 
acquisition and handling by 20%, or more than $1 0 million per year. 
Our purpose in writing is to communicate the strategies and goals we are pursuing to achieve 
responsible savings in the area of supplies acquisition, including an overview of the process we 
will follow to get there. Most importantly, we need your understanding, commitment and help in 
making informed decisions that ensure appropriate care and savings too. Our individual project 
plans will become more focused in the coming weeks, positioning us to interface with you both 
individually and collectively. We wish to engage your assistance as appropriate and to provide 
opportunities for addressing any questions or concerns you might have. 
We also need your help in the near term with regard to new product requests. We ask that new 
product requests be made only if you deem them to be essential for patient care. As you read on, 
the basis of asking your cooperation on this matter should become clear. If you do have an 
essential request, please follow the current process in your area. 
To pursue supply cost savings, L VH has initiated a program called Procurement FOCUS 1998. 
This is a comprehensive effort designed to assure that quality and clinical need criteria are met 
while we responsibly reduce supply costs on a ''total-in" basis. The ''total-in" approach is an 
indication that we are not looking solely at the acquisition cost, but also the variety of products 
and suppliers we use (standardization) and the rate of usage (utilization) in rendering care, plus 
the logistics activities (ordering, invoicing, handling, inventorying), as important components of 
overall cost. 
Market research, including some focused benchmarking, indicates that 75% of our available 
savings will come from standardization/utilization improvements in concert with clinical path 
development efforts; 15% of savings will come from better pricing available through increased 
volume commitments to selected suppliers; and, 10% of savings will result from improved 
logistics, including the implementation of processes that rely heavily on electronic data 
interchange (ED I) to process transactions which for the most part are manual in nature today. 
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We presently have several speCialty product standardization initiatives underway. For example, 
we have been working with the orthopedics division for nearly a year, and have standardized 
from seven suppliers to three for implants. With more work to be done, we have saved nearly 
$600,000 from this effort through a combination of volume commitments and price concessions. 
In cardiology, we have a multi-disciplinary team consisting of physician leaders, administrators, 
and supplier services personnel looking at pacemakers and implantable defibrillators. The goal 
of this group is to standardize to the fewest possible suppliers while assuring that the products 
provide the necessary features and functions. We expect the chosen suppliers, in exchange for a 
volume commitment from us, will offer substantial pricing concessions. 
In the common med/surg product area, L VH has chosen seven manufacturing partners. The 
names of these companies and the categories for which they have been selected are reflected on 
the attachment. These companies were chosen as a result of a thorough review against very 
specific criteria including: 
nationally recognized organizations with major market share 
willingness to commit to a long term relationship 
clinical resources to support product standardization/utilization efforts 
with medical staff 
high quality products at competitive prices 
demonstrated capability to implement electronic commerce 
focus on continuous improvement and innovative supply management 
programs 
willingness to go at risk with L VH for achievement of savings 
Our goal is to move as much product as is acceptable clinically to these organizations. In 
exchange, the companies will commit to the best pricing available and to facilitating informed 
standardization/utilization efforts. As the conversion initiatives are more specifically defined, 
we will solicit the involvement and opinions of physician leaders We will attempt to assure that 
we are drawing the right people into our efforts at the right level to make the right decisions. 
Success with Procurement FOCUS 1998 is expected to benefit all who are associated with L VH 
by assuring continued access to needed supplies in a more cost effective and efficient manner. 
Organizationally, it will aid us in being more cost competitive in the ever changing environment 
of managed care. We look forward to your participation. 
Sincerely, 
Robert X. M by, Jr.,~- Liebhaber &/~ Stuart S. Paxton 









Common Medical/Surgical Supply 
Manufacturing Partners 
~~ DIBRAUN (spinals, epidurals, vascular access, needless 
technology) 
·03LNillD (urologicals, wound suction, vascular access) 
'JI 
~1a f<ErlD.~I£11 
·· :f l .-~ .~il ~;. . •·• 1.•ftnS • .·, .i·.-~··: 
~ ~~ALLINCKRODT 
~~ Et~Gaw, 
(needles, syringes, IV catheters, vacutainers) 
(packs, paper gowns) 
(contrast media, airway managen1ent, anesthesia 
products) 
(IV solutions, sets, pumps, needless technology) 







)THERAPEUTICS AT A GLANCE 
The following actions were taken at the May -July -1997 Therapeutics Committee Meeting Maria Barr, Pharm.D., BCPS, Rebecca 
Hockman, Pharm.D., Howard Cook, R.Ph, BCNSP, FASHP 
THERAPEUTIC COMMITTEE 
CHARTER UPDATE 
The Therapeutics Committee, formerly Pharmacy 
and Therapeutics Committee, reviewed and 
approved a new charter. The charter reflects the 
new committee name, Therapeutics Committee, 
and the committee responsibilities and goals 
which will affect the Lehigh Valley Health 
Network. 
The responsibilities include: 
1. The development or approval of policies 
and procedures relating to medication use 
and therapeutics. 
2. Hospital Formulary Management. 
3. Review of all significant adverse drug 
reactions. 
) 4. The monitoring and evaluation of drug 
usage for the purpose of identifying 
opportunities to improve use, prevent 
problems, and provide safe and effective 
therapy at the lowest reasonable cost 
(phannacoeconomics). 
5. The review and evaluation of all 
significant medication errors. 
6. Participation, as appropriate, required in 
the quality assessment and credentialing 
process. 
7. The preparation and submission of written 
reports of the committee's findings, 
conclusions, recommendations, and 
actions to the Medical Staff through 
Medical Executive Committees as well as 
directly to the Medical Staff and others 
via the Therapeutics Committee 
Newsletter. 
The Goals of the Therapeutics Committee are: 
1. Creation and ongoing maintenance of, 
) through multidisciplinary participation, a 
· disease-management based Formulary 
assuring optimal patient outcomes. 
2. Seek opportunities to continuously 
improve the medication use process within 
the Lehigh Valley Health Network, 
assuring optimal patient outcomes. 
For more information on the Therapeutics 
Committee, please contact Fred Pane, Director of 
Pharmacy at Ext. 8882. 
NEW FORMULARY REQUEST 
PROCESS APPROVED 
The Therapeutics Committee approved a new 
process, to have a medication (therapy) 
reviewed, in order to be added to the Lehigh 
Valley Hospital Formulary. A formulary request 
form, will no longer be used. A request to have 
therapy evaluated for formulary consideration, 
can be made by contacting the Clinical Pharmacy 
Office at Ext. 8884. 
Formulary drugs are therapeutic or diagnostic 
agents recommended as essential, for the best 
possible patient care (outcomes) and whose place 
in therapy is established with a minimum of 
duplication by other agents in the Formulary. 
Drugs to be added to the Formulary, will be 
evaluated by: 
unique place in therapy 
advantages/disadvantages compared to 
formulary agent 
therapeutic impact 
therapy acquisition price 
potential therapy deletions or alternatives 
alteration of resource utilization 
effect.on patient outcome and expected 
length of stay (LOS) 
laboratory costs/testing 
inpatient and outpatient use 
If you have any questions related to this new 
process, please contact the Clinical Pharmacy 
Office at Ext. 8884. 
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ADVERSE DRUG REACTION 
REPORTING AND 
DOCUMENTATION 
A Therapeutics Subcommittee met to discuss and 
evaluate the Adverse Drug Reaction (ADR) 
reporting system at LVH. Issues presented for 
discussion were: 
1) Current JCAHO recommendations for 
ADR reporting 
2) The effectiveness of the current ADR 
reporting system at L VH 
3) Effective utilization of ADR information 
4) Methods of follow-up and ADR reporting 
to the physician and patient 
5) Documentation of ADR's in the patient 
chart and in Phamis 
Following a lengthy discussion, the subcommittee 
made the following recommendations: 
1) Investigate the creation, within the Phamis 
system, of a single, uniform ADR/ Allergy 
screen which is accessible to any 
caregiver in the network 
2) Defme and clarify current reaction 
classifications on the ADR Documentation 
Form to assure clear, accurate ADR 
reporting 
3) Create a card/letter notification system for 
the patient and physician addressing 
suspected/confirmed Adverse Drug 
Reactions. This system must be uniform 
throughout the network. 
The above recommendations were accepted by 
the full Therapeutics Committee. 
EPIDURAL CLONIDINE FOR 
CHRONIC SEVERE PAIN 
Epidural Clonidine, available under the trade 
name DuraclonR, has been approved for use at 
L VH. It is indicated for continuous epidural 
administration as an adjunctive therapy with 
intraspinal opiates for the treatment of severe 
pain in cancer patients that is not adequately 
relieved by opioid analgesics alone. It is more 
likely to be effective in patients with neuropathic 
pain than somatic or visceral pain. 
Hypotension is the most common adverse effect, 
which increases in frequency when clonidine is 
administered with narcotic analgesics. The drug 
readily partitions into plasma via epidural veins 
and therefore exerts systemic effects. Tricyclic 
antidepressants may antagonize the hypotensive 
effects of clonidine - beta blockers may increase 
the risk of rapid rise in blood pressure if epidural 
clonidine is abruptly discontinued. 
The drug is given as a continuous epidural 
infusion beginning at 30mcg/hr. The dose can 
be titrated based on clinical response. Infusion 
rates above 40mcg/hr should be used with 
caution. The drug may be used alone or 
combined with morphine or bupivacaine. 
Standard concentrations for inpatient and 
implantable pumps are available in the revised 
Hospital Formulary appendix. 
A NEW AGENT FOR USE IN 
ALZHEIMER'S DISEASE 
Donepezil hydrochloride (AriceptR , Eisai Inc 
and PriZer Inc), a newly approved agent for the 
L VH Formulary, is FDA indicated for the 
treatment of mild to moderate dementia of 
Alzheimer's type. 
Donepezil differs structurally from tacrine 
hydrochloride (CognexR), but possesses the same 
mechanism of action - acting centrally to 
reversibly inhibit acetylcholinesterase. In the 
mild to moderate stages of Alzheimer's, research 
demonstrates that cognitive dysfunction is 
associated with reduced cortical acetylcholine 
levels. The inhibition of acetylcholinesterase 
may increase cholinergic levels resulting in 
enhanced cognitive function. Unfortunately, 
these agents do not alter the progression of the 
disease. 
The pharmacokinetics of donepezil are 
characterized by rapid Gl absorption, high J 
plasma protein binding (96%), hepatic 
metabolism with urinary excretion of intact drug 
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at 57%, and an extensive elimination half-life of 
yo hours. The hepatic metabolism occurs .. 
'through the cytochrome p450 system at the 
isoenzymes CYP2D6 and CYP3A4. To date, 
pharmacokinetic studies performed with 
theophylline, cimetidine, warfarin and digoxin 
reveal no significant interactions. High plasma 
protein binding and CYP450 metabolism may 
lend caution for many potential drug interactions. 
Clinical efficacy with dozepezil has been shown 
only in placebo controlled trials of 12-24 weeks 
duration. A variety of assessment scales were 
used in these trials. These scales encompass 
neurophysiological test scoring; subjective 
assessments by health care practitioners, patients, 
and families; and evaluations of behavior and 
abilities to perform activities of daily living. 
Benefits were statistically significant, but 
minimal in clinical improvement. 
The most common adverse effects include 
, nausea, diarrhea, vomiting, insomnia, muscle 
)cramps, fatigue, and anorexia. Adverse effects 
· are seemingly dose related. 
The initial starting dose is 5mg by mouth once 
daily. The extensive half-life translates to 
approximately 15 days to attain steady state. A 
. four to six. week titration period is recommended 
before escalating to the maximum daily dose of 
lOmg/day. LVH cost/day of therapy is 
approximately $3.20 compared to $4.28 for 
tacrine. 
Therapeutic advantages of donepezil versus 
tacrine include once daily dosing, and the lack of 
abnormaliti~s in liver function tests. No 
manufacturer requirements exist for hepatic 
enzyme monitoring, as do with tacrine. 
Disadvantages surround the lack of comparative 
data with tacrine, and short duration of controlled 
clinical trials. 
. The Therapeutics Committee at L VH voted to 
) add donepezil to the formulary, while 
simultaneously deleting tacrine. 
VALPROIC ACID- NO 
LONGER JlfST PO 
Valproic Acid Sodium Injection (Depacona, 
Abbott Labs) - The L VH Therapeutic 
Committee voted to extend the formulary to 
include Valproic Acid Sodium Injection. The 
approved indication for valproic acid IV is when 
oral administration is temporarily not feasible. 
The pharmacologic, pharmacokinetic, adverse 
effect, and drug interaction profiles are the same 
as those with PO therapy. These include the 
manufacturer boxed warning for contraindication 
in patients with liver dysfunction. Most common 
adverse effects include dizziness, headache, 
nausea, injection site pain and injection site 
reaction. As with PO therapy, there is no 
reliable association between plasma drug levels 
and clinical efficacy, but the therapeutic range is 
considered to be 50-lOOmg/ml. 
The conversion from PO to IV therapy is simple 
and convenient. When switching from PO to IV 
use the same total daily dose IV as used PO, and 
administer with the same frequency as PO. 
Valproate sodium is to be mixed with D5W, 
Normal Saline or Lactated Ringers and infused 
over 60 minutes (maximum rate of 20mg/min) . 
Clinical data is not available for treatment 
beyond 14 days in duration. In comparison with 
oral therapy, the L VH cost for 500mg of 
valproate sodium IV is $7.20, versus $1.06 for 
valproic acid (DepakeneR) or $1.03 for 
Divalproex (DepakoteR). 
IV HEPARIN THERAPY: 
APPROPRIATE DOSING 
Though not widely utilized throughout the 
institution a weight -based preprinted physician • s 
order sheet is available for use at L VH. A 
Therapeutics Subcommittee met to discuss proper 
utilization of the order sheet, dosing for obese or 
morbidly obese patients and appropriate 
monitoring of IV heparin therapy. 
In reviewing variation in IV heparin dosing, a 
retrospective analysis of patients with the primary 
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diagnosis of pulmonary embolism was conducted. 
Though a small sample size, the time to reach a 
therapeutic aPTT with a weight based-heparin 
dosing vs other dosing methods revealed an 
average of 8.2 hours compared to 59.4 hours, 
clearly supporting the use of the weight based 
method for heparin. The committee felt strongly 
that weight-based heparin protocol and utilization 
of the order sheet should be routinely used for 
suspected or documented PE or DVT. 
To properly communicate and promote the 
utilization of the weight -based heparin order 
sheet, the subcommittee will develop a pocket 
card would assist with heparin dosing as well as 
assure residents are reeducated. A possible joint 
grand rounds with surgery and medicine may 
assist with education of the staff. (The pocket 
cards are presently being developed). 
With such variability in weights of patients, 
much confusion has arisen with what weight to 
use for dosing in the obese or morbidly obese 
patients with regard to heparin. Though sparse 
literature support, the subcommittee concluded 
TOTAL BODY WEIGHT rather than an adjusted 
body weight should be used. It was concluded · 
the benefit of attaining a therapeutic aPTI sooner 
rather than later outweighed the risk. The 
clarification of using TOTAL BODY WEGHT 
will appear on the next revision of the preprinted 
heparin order sheet. Of note, the subcommittee 
agreed the comparison of using total body weight 
vs an adjusted body weight and the time to attain 
a therapeutic aPTI and outcome would be an 
excellent research project. 
The final topic of appropriate heparin monitoring 
regarding correlation of therapeutic aPTI with 
heparin levels is still being discussed. The 
subcommittee recommended an adjustment to the 
heparin order sheet with regard to heparin levels. 
The statement, "If heparin dose > 1500 unitslhr, 
order heparin level o yes o no" will be changed 
to "If heparin dose > 20 units/kglhr, ·without 
attaining a therapeutic aPTI, obtain heparin level 
o yes o no. " This would provide consistency 
with the weight-based order sheet. 
Stay tuned for further information regarding 










HOSPITAL Residency Education Survey 
Center for Educational Development and Support 
Previous surveys covered a general overview of information technology in medical education. 
In an effort to gain insight into more specific needs or desires for implementing technology into 
residency education, we ask that you take the time to complete this assessment. 
1. What technologies have you implemented or would you implement into your teaching if 
they were easily accessible within the L VHHN system? 
MODALITY IMPLEMENTATION 
CURRENTLY INTERESTED 
COMMENTS USING IN USING 
Computer-based education 
Interactive multimedia 
Drills and practice 















2. What specific programs or software would you like to implement as part of your 
teaching? 
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3. If programs are not commercially available, would you be willing to create your own 
multimedia programs with the help of the Instructional Design group or by 
using a non-programmer authoring package? 
4. Have you seen, or are you aware of specific programs or technologies that are presently 
in use at other institutions which you would like to emulate? If yes, please specify. 
5. Would you be more inclined to implement technology-based training (i.e., virtual 
reality, interactive multimedia) if any or all of the below-listed items were in place at 
L VH? (check any that would be applicable) 
0 Computer lab with equipment support available (learning resource center) 
0 Access to programs at workstations throughout L VHHN 
0 Access to programs through the Intemet/intranet 
0 Access to programs from remote locations 
0 An automatic computer training management system (keeps track of student progress 
and performance while using computer-based training) 
0 Medical informatics program (to help physicians become comfortable with technology) 
0 CD-ROM drives on computers allowing for use of interactive multimedia training 
0 Assistance with evaluation and recommendations for software ) 
6. In what areas do you see a need for additional educational support or training regarding 
residency education? 
7. Are there specific courses or programs you would like to see offered as part of the 
residency curricula here at L VH? (e.g., courses on HMOs, business practices, ethics, 
bedside manner, etc.) 
8. Comments or suggestions (Feel free to use additional paper for your answers): 
Name (optional, but appreciated) Phone ------
Please return surveys to Dean Shaffer, Instructional Design Group, Center for Educational Development and Support, ) 
Suite 407, JDMCC. If you would like to discuss any of these issues, please contact Dean Shaffer, (610) 402-0055. 
resquest.ppt 07197 
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INFORMATION MANAGEMENT SURVEY 
• J 
) 
Information Services is conducting this survey to assess computer system strengths, weaknesses and opportunities for 
improvement and to comply with JCAHO Information Management requirements. Your input is very important to the 
success of this project. Please send the completed survey to: Nancy O'Connor, Information Services, 2024LS by August 
22, 1997. Thank you for your help. 
Please circle one: Attending MD Resident Practice Manager Other 
Please circle the most appropriate answer. 
1-poor/none, 2-fair, 3-good, 4-very good, 5-excellent/to a very great extent, NA-not applicable 
l. Rate the liS staff based on the following criteria: 
helpfulness 2 3 4 5 NA 
friendliness 2 3 4 5 NA 
politeness 2 3 4 5 NA 
overall knowledge of application or work process 2 3 4 5 NA 
providing alternative solutions to work problems 2 3 4 5 NA 
2. Rate the knowledge the liS staff has concerning: 
your office and its work processes 2 3 4 5 NA 
PHAMIS 2 3 4 5 NA 
Email 2 3 4 5 NA 
Departmental systems (please specify) 
2 3 4 5 NA 
2 3 4 5 NA 
2 3 4 5 NA 
3. Do you know who to call in Information Services when you have a problem during the following times: 
0700-1700 YES NO 
1700-0700 YES NO 
) weekends, holidays YES NO 
4. Rate how quickly Information Services solves the questions you call about. (circle one) 
within minutes same day next day takes quite awhile never NA 
5. Do you usually get transferretl to someone else or is your call handled by the person who answers it? (circle one) 
handled by person answering transferred NA 
6. When you call liS Customer Service, how long are you on hold before someone helps yo~? (circle one) 
more than a minute less than a minute a few seconds not put on hold 
7. Rate the liS Customer Service Automated Call Distribution (ACD) message/call handling. 
1 2 3 4 5 NA 
8. Are the choices clear to determine what ACD line to select? YES NO 
9. How well are PC software products supported? (e.g., WordPerfect, Word, Lotus, Excel)? 
questions answered expediently and thoroughly 1 2 3 4 5 NA 
there is an understanding of the priority of the problem I 2 3 4 5 NA 
10. Rate how well major system downtimes are handled. 2 3 4 5 NA 
11. Rate liS related training based on the following criteria: 
completeness of training: covers all aspects of systems you use 1 2 3 4 5 NA 
relativity of training: covers how you'll use system on daily basis 1 2 3 4 5 NA 
teaching materials effective, available 1 2 3 4 5 NA 
) classes available when needed 1 2 3 4 5 NA 
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12. Which methods of training work best for you and your staff? (Check all that apply.) '. 
D classroom with hands-on practice- Internal (on campus) 
D classroom with hands-on training- External (training centers, technical schools, etc.) 
D large group overview with l'lb hands-on practice 
D self paced computer based training (CBn 
) 
D self paced video based training 
D 
13. Rate how well Information Services institutes changes you have requested based on the following criteria: 
the duration of the project was timely considering its scope 1 2 3 4 5 NA 
the change is made according to what has been requested 1 2 3 4 5 NA 
how the changes are communicated to you during the process 1 2 3 4 5 NA 
14. Rate how well liS is able to allocate staff to support projects affecting your office. 
flexible, able to accommodate priorities 1 2 3 4 5 NA 
staff is knowledgeable, well suited to the assignment 1 2 3 4 5 NA 
communication of how staff is allocated to departments 1 2 3 4 5 NA 
15. Do you understand the liS project request process? YES NO 
16. Rate your level of satisfaction that the current computer applications are meeting your needs today. 
1 2 3 4 5 NA 
17. Rate the timeliness of the information you need from: 
PHAMIS 2 3 4 5 NA 
Email 2 3 4 5 NA 
departmental system 2 3 4 5 NA 
18. Rate your level of confidence that the data and information is correct from: · 
PHAMIS 2 3 4 5 NA 
Email 2 3 4 5 NA 
departmental system 2 3 4 5 NA 
19. Rate how well the reports from your system give you the information required to: 
) 
plan, manage, reprioritize functions. 1 2 3 4 5 NA 
perform your daily duties 1 2 3 4 5 NA 
report data to upper management 1 2 3 4 5 NA 
20 Rate the logon/signon process based on the following criteria: 
easy 2 3 4 5 NA 
quick 2 3 4 5 NA 
secure 2 3 4 5 NA 
21 Do you have access to the data and information you need to do your job well. YES NO 
22 Are you getting too much information? YES NO 
23 Please estimate PHAMIS' overall impact to your job. (Check all that apply.) 
D has helped in my day to day job functions 
D has added extra work to my day to day job functions 
D has not affected my day to day job functions 
D other (please explain) 
24 Please estimate Email's overall impact to your job. (Check all that apply.) 
D has helped in my day to day job functions 
D has added extra work to my day to day job functions 
D has not affected my day to day job functions 
D other (please explain) 
25. Describe your future needs for information. List the top five (5), high priority requirements. 
) 






POLICY #: AD 1601. 00 
SUBJECT: Restraint and 
Seclusion 
EFFECTIVE DATE: 
AREAS AFFECTED: All Departments 
PAGE: 1 of 6 
I. POLICY 
The facility complies with the Pennsylvania Bill of Rights, and the 
Standards of the Joint Commission on Accreditation of Healthcare Organizations 
(JCAHO). 
It is the practice of the facility to use restraint and seclusion in 
clinically appropriate and justified situations when other less restrictive, 
or non-restrictive interventions are not sufficient or not available. 
Patients' rights, dignity, and well-being are supported and maintained. 
Restraint and/or seclusion is never used in a manner which causes undue 
physical discomfort, harm or pain to the patient or as a form of punishment, 
discipline or for the convenience of staff. 
Restraint or seclusion may be used in response to an emergent and/or 
dangerous behavior or addictive disorder (as described in Section IV, C) as an 
adjunct to planned care, a component of an approved protocol, or, in some 
cases, as p~rt of standard practice. Standard care (as described in Section 
IV, A) does not require a physician's written order, nor does use of restraint 
as part of an approved protocol that has clear criteria for use in assessing a 
patient's need for restraint. 
) Emergent use of restraint and/or seclusion may be initiated before 
obtaining a physician's order when the assessing RN or other trained 
authorized member of the health care team determines the need for immediate 
intervention to prevent the patient from harming self, others, property, or 
treatment environment. The health care team works together in the emergency 
application of restraint. When it is determined that help must be obtained, 
the team continues to work with the patient to use the least restrictive 
method possible, until the decision is agreed upon to restrain the patient. 
Assessment of patient need and a time-limited physician's written 
order are required for use of restraint or seclusion in behavioral health 
areas (as 'described in Section IV, D)and when a patient's assessed need 
requires the use of restraint outside a defined, approved protocol. A verbal 
order must be obtained within one (1) hour. In Behavioral Health, time-
limited orders are restricted to: 4 hours for adults, 2 hours for children 
and adolescents (ages 9-17), and 1 hour for children under age 9. An RN may 
reassess the patient and make the decision to continue the original order for 
additional periods not to exceed 24 hours if specified in the original order. 
The individual applying the restraint is responsible for the correct, 
safe application of the restraint device. 
II. SCOPE 
Personnel trained in the proper use of restraint and seclusion. 
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III. DEFINITIONS 
.. 
Personne1 - includes, but is not limited to, all employees, medical 
staff, allied health professional staff, students, volunteers, and others 
engaged in any activities at the hospital, excluding patients and visitors 
(JCAHO). 
Physical restraint - voluntary or involuntary use of any method 
physically restricting a person's freedom of movement, physical activity, or 
normal access to his or her body, as either part of an approved protocol or 
use of individual orders. 
Seclusion - involuntary confinement of a person alone in a room where 
the person is physically prevented from leaving. 
Types of restraints - locked limb, locked waist, locked Geri chair 
bar, cloth limb, mitts, bedrails (when used to keep a patient in bed). 
Types of immobi1ization devices - cloth limb or extremity 
holders/immobilizers, mitts, soft belts, siderails as used per protocol 
guidelines (Attachment A) . 
Service specific forms - documentation form that may include but not 
limited to Critical Care Flowsheet, Restraint and Seclusion Flowsheet. 
IV. PROCEDURE 
A. Standard Care 
1. 
Action 
Use of restraint devices on patients 
without a physician's order is acceptable 
under these standard conditions: 
• during transportation via wheelchair, 
stretcher, or any transportation vehicle. 
• during medical, diagnostic, surgical 
procedures or tests. 
• as adaptive support to achieve maximum 
normative bodily functioning or to 
posturally support the patient (i.e., 
orthopedic appliances, braces, 
wheelchairs, Geri chairs). 
• as protective devices intended to 
compensate for a specific physical 
deficit or prevent safety events 
not related to cognitive dysfunction 
(i.e., to prevent a cognitively intact 
patient from falling out of a chair 
due to a physical inability to support 
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PROCEDURE (Continued) 






• forensic/correction restrictions used 
for security purposes (Refer to Emergency 
Preparedness Policy EP2004.00). 
Assess patient to determine need for 
standard restraint device(s). 
Perform customary patient care and 
regular hourly observation of patient. 
Document use of standard restraint 
device(s) on service specific forms (as 
indicated). 
Reassess patient to assure the standard 











Apply appropriate soft immobilization 
device when less restrictive interventions 
are ineffective and patient is in imminent 
danger to self or others. Less restrictive 
interventions may include: 
• verbal interventions 
• decrease of environmental stimuli 
• family/significant other supervision 
Initiate Sedated/Anesthetized, Brain injured/ 
cognitively impaired Patient Protocol. 
Document .use of protocol on Restraint/ 
Observation Checklist or service specific 
form, as appropriate. 
4. · Perform customary patient care and 
regular hourly observation of patient. 
5. 
6. 
Reassess patient to assure the sqft 
restraint continues to meet patient need. 
Remove soft immobilization device when 
the patient demonstrates a reduction of 
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PROCEDURE (Continued) 









Notify physician immediately (verbal order 
must be obtained within 1 hour when 
emergency application of restraint or 
seclusion is necessary; the order is time 
limited and not to exceed 24 hours). 
Co-sign and date verbal order within 24 
hours, if applicable. 
Remain with a violent patient until the 
devices are correctly applied, and proce-
dures for appropriate observation and 
care of the patient are initiated. 
Protect the patient's dignity, modesty, 
and well-being. 
Document the following: 
• events leading up to the intervention. 
• prior use of alternative measures. 
• patient's response to alternative measures. 
• time restraint/seclusion was initiated. 
• time restraint/seclusion was terminated. 
Observe the patient every 15 minutes. 
Offer the following: 
• use of the bathroom, bedpan or urinal 
as appropriate for the patients condition 
• provide for meals and fluids at least 
every 4 hours 
• Provide regular hygiene and skin care 
• check color, motion, and sensation of 
the restrained extremity 
perform range of motion, as needed 
8. Document on the Restraint and Seclusion 
Flow Sheet. 
9. Discuss the use or possible use of restraint 
and seclusion with the patient and/or family 
whenever possible. 
10. Write a new order every 24 hours following 
a face-to-face assessment. 
11. Document the use of restraint and/or 
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IV. PROCEDURE (Continued) 





Write time-limited order for no more than: 
4 hours for adults 
2 hours for children and adolescents 
(ages 9 to 17) 
1 hour for children under age 9 
(Order may specify that RN may continue 
original order for up to 24 hours). 
Reassess the patient and make the 
decision to continue the original order for 
additional periods not to exceed 24 hours if 
specified in the original physician order. 
Observe the patient every 15 minutes 





• use of the bathroom, bedpan or urinal 
as appropriate for the patients condition 
• provide for meals and fluids at least 
every 4 hours 
• provide regular hygiene and skin care 
check color, motion, and sensation of 
the restrained extremity 
Release restraint or seclusion before the 
time limit based upon monitoring and 
reassessment. 
Reapply the original order if release time is 
less than one (1) hour and the same behavior 
is evident. 
Document reduction or early termination of 
restraint/seclusion on the Restraint 
Observation Checklist (Nsg. 37). 
Document the use of restraint and/or 










Protocol Guiding the Use of Protect/Immobilization Devices for the 







VIII. POLICY RESPONSIBILITY: 
Patient Care Services 
IX. REFERENCES 
Policy: AD 1600.01 
President & CEO 
Title 
President of Medical Staff 
Title 
Vice-President of Nursing 
Title 
IN COORDINATION WITH: 
Legal Services 





Comprehensive Accreditation Manual for Hospitals: The Official 
Handbook, 1997 standards. 
X. REVISION 
6 of 
Hospital reserves the right unilaterally to revise, modify, review, 
rescind or alt~r the terms and conditions of this policy within the 

















Protocol Guiding the Use of Immobilization Devices for the 
Sedated/ Anesthetized, .Brain Injured/Cognitively Impaired Patient 
Purpose: 
The purpose of this protocol is to assist in the identification of patients at risk for injury and the 
interventions to be utilized prior to the use of protective and immobilization devices. 
Protocol: 
1. The following are observations/behaviors which may place the patient at risk for injury: 
Improper body alignment 
Pulling at TV's, tubes 
Impaired judgment which 
compromises or 
exacerbates condition 
Unable to remember instructions 





Recent fall/risk for fall 
Low level of consciousness (can be 
aroused, but unable to maintain 
wakefulness) 
2. The following are interventions to be utilized when appropriate to the patient situation in an attempt 
to maintain patient safety and freedom of mc:..vement and prior to the use of protective/ 
immobilization device: 
Glasses/hearing aide 
Frequently used items placed 
close to patient 












Increased observation level 
Move patient to room close to 
nurs~s' station 
Diversional activity 
3. If in spite of attempting the appropriate foregoing interventions, the patient's at risk status/behavior 
persists, an RN may decide to apply an immobilization device (i.e., soft limb holders). The device 
chosen will permit the greatest freedom of movement consistent with patient safety. 
Devices are applied according to manufacturer's instructions and hospital policy. 








DOCTOR'S ORDER SHEET_ 
DRUG INTOLERANCES: REACTIONS: ) 
DRUG ALLERGIES REACTIONS: 
D NONE KNOWN 
DATE & TIME UNIT NURSE 
HT • DOCTOR'S ORDERS 
ORDER 
CLERK SIGNATURE l't'l~itl:a'''J••:I:tW!l"'~·:f!,.,.:l•JI~I·:.I=-~I.eJ~I~ INITIALS WT WRITTEN lnM£ AND TIME 
RESTRAINT/SECLUSION ORDERS J=>age 1 of 1 
Date and time must be provided for order to be initiated! 
1. Restrain patient with: 
0 4 point locked limb 0 locked waist 0 wrist (cloth limb) 
0 2 point locked limb 0 geri-chair w/locked bar 0 ankle (cloth li'!J_!}) 
0 chest strap (Psych/EO only) 0 mitts Oseclusion 
2. Purpose for restraint(s)/seclusion 
0 high risk for self-harm 0 high risk for causin~significant 
0 high risk for harm to others disruption of treatment environment 
0 high potential for removing tubes 0 other 
equipment, lines, etc 
3. Criteria for discontinuing restraint(s)/seclusion L 
0 no aggressive behavior 0 no risk for ~using significant 
0 no aggressive behavior threatened disruption of treatment environment 
0 no suicidal behavior O_pa~~l)!_ is not destructive of property 
0 no suicidal behavior threatened 0 no potential for removing tubes, 
0 no self-harming behavior equipment, lines. etc. 
0 no self-harming behavior threatened Oother 
4. Patient to be restrained/secluded for up to hours (not to exceed 24 hours) 
5. PSYCH/A TRYIBEHA VIORAL HEALTH PATIENT: 
0 adult-restrain for up to 4 (four) hrs 0 RN will reassess patient and may 
0 child/adolescent-restrain for up to 2 (two) hrs continue original order for additional periods 
0 child (under age 9)-restrain for up to 1 (one) hr up to_._ hours (not to exceed 24 hrs) 
*RN Signature Time ~~~tin~; *RN Signature Time ~~~tin~~ 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 ' li 
0 0 0 0 
*Supportive documentation required in Progress Note 
--- .. .. . . 
M.D./D.O. 
.. 






1. LEVEL OF PRECAUTION: 
01 : 1 Oq 15 min. Oq 1 hr 
2. REASON: 
0 New Admission 0Behavior 
0 Seclusion 0 Visual Observation 
0 Elopement 0 Close Observation D Suicide Precaution 0 Restraint~ 
0 Sedated/Anesthetized, Brain lnjured/Cognitively Impaired Protocol 




TYPE OF RESTRAINT 
SIDE RAILS UP 
OFFER TOILET q 2 hr 
OFFER FLUIDS q 1 hr 
CIRCULATION CHECKS 
ROMq 2 hr 
SEE PROGRESS NOTE 




TYPE OF RESTRAINT 
SIDE RAILS UP 
OFFER TOILET q 2 hr 
OFFER FLUIDS q 1 hr 
CIRCULATION CHECKS 
ROMq 2 hr 
SEE PROGRESS NOTE 
TIME 0115 ouo IW -INITIALS 
PATIENT LOCATION 
PATIENT BEHAVIOR 
TYPE OF RESTRAINT 
SIDE RAILS UP 
OFFER TOILET q 2 hr 
OFFER FLUIDS q 1 hr 
CIRCULATION CHECKS 
R0Mq2hr 
SEE PROGRESS NOTE 
PATIENT LOCATION 
BR = Bathroom B =Bed 
CR • Consultation Room c =Chair 
DR = Dining Room L =Litter 
LR = Laundry Room w = Wheelchair 
PR = Patient Room GC = Gencha1r 
OR "' Quiet Room 0 =Off Unit 
RR = Recreation Room 
SR = Smoke Room 
H =Hallway 




Ot30 Ot.S 0200 0215 0230 
0530 05&5 11600 liltS 0130 
0131 DM5 tOOO 1015 t030 
PATIENT BEHAVIOR 
A • Angry SH • Self Harm 
AS • Assaultive T = Tearful 
C = Cooperative 
U • Uncooperative 
CB = Combative 
I "' Intrusive 
P = Pac•ng 
a = Quiet/Subdued 
R =Restless 
.S ,. ,s,~c~,;..., 
SIDE 1 of 2 
02.S 0300 03t5 0330 u.s 
OW$ 0700 D7t5 0730 07.S 
10U t1DO tt15 mo 
TYPE OF RESTRAINT 
x.c = 4 pt. locked limbs 
11.S 
X2 = 2 pt. alternate limbs (locked) 
CS = Chest Strap 
LW =Locked Waist 
S = Seclus1on 
GCJB = Gerichatr w/locked bar 
W = Wrist (cloth limb) 









• No potential for injury 
to self/others 
1 
DO NOT RESTRAIN 
GSB\proccdur\attachN I .rst 6/97 
ATTACHMENT C 
RESTRAINT ALTERNATIVES DECISION TREE 
ASSESSMENT 
• Potential for Self Injury 





• Treat or Eliminate Cause 
• Try Alternatives to Restraints 
(See page 2) Column I 





Patient behavior unchanged 
Potential for Iury to self/olhers 






Patient behavior unchanged 
Potential for irry to self/others 
APPLY RESTRAINTS 
• Establish criteria for removal 
• Continued evaluation of 









) COLUMN I .. COLUMN II 
Least Restrictive 
• Continue verbal interventions 
Changing or eliminating bothersome treatments 
• Initiate oral (as opposed to IV or NG) feedings. • 1:1 nursing observation 
• Remove catheters and drains as soon as possible . 
• Medication 
• Remove patient to an area of decreased 
stimulation 
Modifying the environment • Show of force 
• Increase or decrease the amount of light in the room, 
depending on glare and the patient's preference or • Escort patient to room 
needs. 
• Position the bedside commode so that the patient can • Behavioral contract 
use it easily. 
• Arrange for patient to be near the nursing station, • Special programming (Psych only) 
kless the stimulation triggers agitation or worsens 
nfusion. • Time out 
• Place the mattress on the floor, so the patient can move 
about freely in bed without falling. • Give direction versus offering choices . 
• Leave the bedrails down if the patient tends to climb 
over them, or use half rails to prevent rolling out of 
bed. 
• Reduce environmental noise . 
• Keep the call button accessible . . Use special furniture accordingly (a lower bed, a 
reclining chair). 
Offering diversionary and physical activities 
• Use TV, radio, or music for diversion (depending on . 
the patient's cognitive capacity and individual 
preferences). 
• Enlist the aid of a recreational .therapist. 
• Provide exercise and ambulation whenever possible . 
• Initiate training in activities of daily living . 
• Use physical and occupational therapists to help the 
)atient increase his strength and endurance and feel a 
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